Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
SJ Busfield, M Biondo, M Wong, HS Ramshaw, EM Lee, S Ghosh, H Braley, C Panousis, AW Roberts, SZ He, D Thomas, L Fabri, G Vairo, RB Lock, AF Lopez, AD Nash
Leukemia | NATURE PUBLISHING GROUP | Published : 2014
Awarded by NHMRC
We would like to the following for their contributions: Bill Panagopoulos and Melanie Pudney (IMVS), Laura McMillan, Kirstee Martin, Daria Kurtov, Matt Hardy and members of the CSL Research Department for excellent technical assistance. Naomi Sprigg for patient sample collection. Hayley Ramshaw is supported by the Peter Nelson Leukaemia Research Fund. Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and the Sydney Children's Hospitals Network. Andrew Roberts is supported by funding from NHMRC (637309, 1016647) and the Leukemia and Lymphoma Society.